Kalpataru Multiplier Ltd.

Our Bank & DP Click for Online Payment MF portfolio login smart way to invest in gold
Sovereign gold bond(SGB) Exchange trades funds(ETF)
CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

Company Profile
more from company profile
HomeMarkets Company Profile Smart Quotes

Smart Quotes

VIMTA LABS LTD.

NSE : VIMTALABSBSE : 524394ISIN CODE : INE579C01029Industry : Pharmaceuticals & DrugsHouse : Private
BSE523.80-9.6 (-1.8 %)
PREV CLOSE () 533.40
OPEN PRICE () 533.05
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 3892
TODAY'S LOW / HIGH ()518.40 538.10
52 WK LOW / HIGH ()365 621.4
NSE523.05-9.4 (-1.77 %)
PREV CLOSE() 532.45
OPEN PRICE () 532.45
BID PRICE (QTY) 523.05 (26)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 30441
TODAY'S LOW / HIGH() 518.00 537.85
52 WK LOW / HIGH ()365.8 623.15
BSE NSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1990

Management Info :

Sivalinga Prasad Vasireddi - Chairman Harita Vasireddi - Managing Director

Registered Office :

Address : Plot Nos 141/2 & 142,I D A Phase I I,Cherlapally, R R District,
Hyderabad,
Telangana-500051

Phone : 040- 27264141

Website : www.vimta.com

Registrar's Details : Cil Securities Ltd
214 Raghava Ratna Towers , Chirag Ali Lane,Abidas,,Hyderabad
Listing : BSE, NSE, MCX
NEWS
01Apr Amalgamation
Inter alia, approved the Scheme of Amalgamation of Emtac Laboratories Pr..
02Mar Vimta Labs gets grants-in-aid from Min
Vimta Labs has received Grants-in-aid (GIA) of Rs 4.09 crore from Minist..
02Mar Vimta Labs informs about updates
Vimta Labs has informed regarding Grant in aid (GIA) of Rs 409.49 lakhs..
28Feb Announcement under Regulation 30 (LOD
Allotment of 5218 Equity shares under Vimta Labs Employee Stock Option P..
24Feb Vimta Labs informs about press release
With reference to letter no. VLL/Sh/089/2023-24 dated 23rd February 2024..
Financials
in Millions
QTR Dec 23 ANNUAL 23
Net Profit94.55472.990000000001
Gross Profit 125.98 638.310000000001
Operating Profit 217.74970.150000000001
Net Sales 800.973151.16
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Ajanta Pharma (BSE)
 2377.00 (6.44%)
M.Cap ( in Cr)
29930.39
Alkem Laboratories (BSE)
 4899.45 (2.36%)
M.Cap ( in Cr)
58580.27
Astrazeneca Pharma I (BSE)
 5424.45 (1.70%)
M.Cap ( in Cr)
13561.13
Dr. Reddy's Lab (BSE)
 6349.95 (0.98%)
M.Cap ( in Cr)
105928.76
Torrent Pharma (BSE)
 2732.60 (2.20%)
M.Cap ( in Cr)
92483.60
Shareholding Pattern
NON-INSTITUTION 56.45%
PROMOTERS 36.92%
MUTUAL FUNDS/UTI 1.49%
FI/BANKS/INSURANCE 0.01%
GOVERNMENT 0%
FII 0%
Mf Holding
ATTENTION INVESTORS

Kalpataru Multiplier Ltd.

Kalpataru is a wishful Divine Tree and in present context a widely Trusted, Time tested and Transparent Share Broker, Mutual Fund Distributor and D.P. of this region.

Mobile Trading App
Mobile Trading IOS App
Call Us 0755-4350141/142/143, 9425008895
Mutual Funds 0755-4276725, 4276726
Email Uskmlho@kalpatarumulti.com

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
SENSEX73878.15-732.96 (-0.98%)
NIFTY22475.85-172.35 (-0.76%)
Dow Jones 38675.68450.02 (1.18%)
Nasdaq 16156.33315.37 (1.99%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI